Association of atherogenic index of plasma with early neurological deterioration in patients with acute ischemic stroke

Clin Neurol Neurosurg. 2023 Nov:234:108014. doi: 10.1016/j.clineuro.2023.108014. Epub 2023 Oct 12.

Abstract

Purpose: To explore the correlation between Atherogenic Index of Plasma (AIP) and early neurological deterioration (END) in patients with acute ischemic stroke (AIS).

Methods: A retrospective analysis of 334 patients diagnosed with AIS between January 2021 and May 2023 at the Affiliated Huai'an Hospital of Xuzhou Medical University. Patients were divided into END and non-END groups based on changes in National Institutes of Health Stroke Scale scores (NIHSS) within 7 days of admission, and the differences in the indicators between the two groups were examined using univariate analysis. The patients were then divided into three groups based on the tertile of the AIP (T1: AIP≤ -0.01; T2: 0 ≤AIP≤0.16; AIP≥0.17), and logistic regression analysis was used to examine the association between the AIP and END. Finally, the predictive ability of the AIP was evaluated using the receiver operating characteristic (ROC) curve.

Results: A total of 334 patients were included, of which 64 (19.20%) had END. The results of the analysis showed that the AIP was significantly higher in the END group compared to the non-END group. Multivariable logistic regression analysis showed that higher AIP was associated with END in AIS patients (OR=3.259, 95%CI, 1.490-7.125, P = 0.003), especially in large-artery atherosclerosis (LAA) subtype (OR=4.240, 95%CI,1.30-13.87, P = 0.017). ROC analysis revealed that the best predictive cutoff value of AIP was 0.115, and the area under the ROC curves for AIP was 0.681(0.604-0.758).

Conclusion: Our study uncovered that higher AIP levels were associated with END development in AIS patients.

Keywords: Acute ischemic stroke; Atherogenic Index of Plasma; Atherosclerosis; Early neurological deterioration; Risk factor.

MeSH terms

  • Atherosclerosis* / complications
  • Brain Ischemia* / complications
  • Humans
  • Ischemic Stroke* / complications
  • Retrospective Studies
  • Stroke* / complications